The Equitable Distribution of COVID-19 Therapeutics and Vaccines

JAMA. 2020 Jun 23;323(24):2462-2463. doi: 10.1001/jama.2020.6641.

Authors

Thomas J Bollyky¹, Lawrence O Gostin², Margaret A Hamburg³

Affiliations

¹ Council on Foreign Relations, Washington, DC.
² O'Neill Institute for National and Global Health Law, Georgetown University, Washington, DC.
³ National Academy of Medicine, Washington, DC.

PMID: 32379268
DOI: 10.1001/jama.2020.6641

No abstract available

MeSH terms

Antiviral Agents / supply & distribution*
Betacoronavirus
COVID-19
COVID-19 Drug Treatment
COVID-19 Vaccines
Coronavirus Infections / drug therapy
Coronavirus Infections / prevention & control
Coronavirus Infections / therapy
Global Health*
Health Services Accessibility*
Humans
Intersectoral Collaboration
Pandemics / prevention & control
Pneumonia, Viral / drug therapy
Pneumonia, Viral / prevention & control
Pneumonia, Viral / therapy
SARS-CoV-2
Viral Vaccines / supply & distribution*

Substances

Antiviral Agents
COVID-19 Vaccines
Viral Vaccines